Evidence map›Paper›PMID 30948625›Full record

ArticleJournal of neurology, neurosurgery, and psychiatry2019

Cortical grey matter sodium accumulation is associated with disability and secondary progressive disease course in relapse-onset multiple sclerosis.

Wallace J Brownlee, Bhavana Solanky, Ferran Prados, Marios Yiannakas, Patricia Da Mota, Frank Riemer, Manuel Jorge Cardoso, Sebastian Ourselin, Xavier Golay, Claudia Gandini Wheeler-Kingshott and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurology, neurosurgery, and psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Clinically feasible BNMR in biomedicine · 2023
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Wallace J BrownleeQueen Square Multiple Sclerosis Centre, UCL Institute of Neurology, London, United Kingdom w.brownlee@ucl.ac.uk.
Bhavana SolankyQueen Square Multiple Sclerosis Centre, UCL Institute of Neurology, London, United Kingdom.
Ferran PradosQueen Square Multiple Sclerosis Centre, UCL Institute of Neurology, London, United Kingdom.
Marios YiannakasQueen Square Multiple Sclerosis Centre, UCL Institute of Neurology, London, United Kingdom.
Patricia Da MotaQueen Square Multiple Sclerosis Centre, UCL Institute of Neurology, London, United Kingdom.
Frank RiemerDepartment of Radiology, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
Manuel Jorge CardosoTranslational Imaging Group, Centre for Medical Image Computing (CMIC), Department of Medical Physics and Bioengineering, University College London, London, United Kingdom.
Sebastian OurselinTranslational Imaging Group, Centre for Medical Image Computing (CMIC), Department of Medical Physics and Bioengineering, University College London, London, United Kingdom.
Xavier GolayDepartment of Brain Repair and Rehabilitation, UCL Institute of Neurology, London, United Kingdom.
Claudia Gandini Wheeler-KingshottQueen Square Multiple Sclerosis Centre, UCL Institute of Neurology, London, United Kingdom.
Olga CiccarelliQueen Square Multiple Sclerosis Centre, UCL Institute of Neurology, London, United Kingdom.
University College London · GBNational Hospital for Neurology and Neurosurgery · GBMultiple Sclerosis Society · GBUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveSodium (

methodsWe performed a cross-sectional study in 96 patients followed up ~ 15 years after a clinically isolated syndrome (CIS) and 34 healthy controls. Disease course was classified as CIS, relapsing-remitting MS or secondary progressive MS (SPMS). We acquired

resultsTSC in all tissues was higher in patients with MS compared with healthy controls and patients who remained CIS, with differences driven by patients with SPMS. Higher CGM TSC was independently associated with Expanded Disability Status Scale (R

conclusionsSodium accumulation in CGM reflects underlying neuroaxonal metabolic abnormalities relevant to disease course heterogeneity and disability in relapse-onset MS. TSC and should be considered as an outcome measure in future neuroprotection trials.

Indexed as

AdultBrainBrain ChemistryCase-Control StudiesCross-Sectional StudiesFemaleGray MatterHumansMagnetic Resonance ImagingMaleMiddle AgedMultiple SclerosisMultiple Sclerosis, Chronic ProgressiveMultiple Sclerosis, Relapsing-RemittingNeuroimagingSodiumSodium

Identifiers

PMID30948625
PMCPMC7611428
OpenAlexW2932672475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.